MUC1 immunotherapy against a metastatic mammary adenocarcinoma model: Importance of IFN-gamma Cover

.blurhash-client-img { display: none !important; }

MUC1 immunotherapy against a metastatic mammary adenocarcinoma model: Importance of IFN-gamma

Volume 37 (2016): Issue 1 (June 2016)

By: Catherine J. Lees, Nechama Smorodinsky, Galit Horn, Daniel H. Wreschner, Ian F.C. McKenzie, Geoffrey Pietersz, Lily Stojanovska and Vasso Apostolopoulos

Open Access

|Jul 2016

Metrics

DOI: https://doi.org/10.1515/prilozi-2016-0001 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345

Journal RSS Feed

Language: English

Page range: 15 - 25

Published on: Jul 15, 2016

Published by: Macedonian Academy of Sciences and Arts

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

MUC1. MHC class I,

interferon-gamma,

Related subjects:

Basic medical science,

History and ethics of medicine,

Clinical medicine,

Clinical medicine, other,

Social sciences,

Education, other

© 2016 Catherine J. Lees, Nechama Smorodinsky, Galit Horn, Daniel H. Wreschner, Ian F.C. McKenzie, Geoffrey Pietersz, Lily Stojanovska, Vasso Apostolopoulos, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 37 (2016): Issue 1 (June 2016)Next article